Who Supplies Citalopram? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Citalopram exports, with 257+ registered manufacturers shipping to buyers across 101+ countries — yet a handful of companies dominate the shipments. MEDISPRAY LABORATORIES PRIVATE LIMITED holds the largest share at 30.4% (export value: $77.3M). Close behind, TORRENT PHARMACEUTICALS LTD (5.6%, $14.4M). MYLAN LABORATORIES LIMITED (5.2%, $13.3M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Citalopram? Top Manufacturers & Their Buyers
Flow of Citalopram from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Citalopram Supplier Network — Key Market Intelligence
The Citalopram export market from India is led by MEDISPRAY LABORATORIES PRIVATE LIMITED, which alone commands a 30.4% share, shipping $77.3M worth of product across 77 shipments. The second-largest exporter, TORRENT PHARMACEUTICALS LTD, contributes $14.4M (5.6%) to the overall market. Combined, the top two suppliers alone account for 36.0% of all Citalopram exports, indicating a relatively concentrated supply base.
Across all 257 tracked manufacturers, the total Citalopram export value stands at $254.5M from 7.4K shipments. The market average shipment value is $34.5K. The single largest buyer relationship in terms of trade value is CIPLA MAROC, receiving $77.0M worth of product.
The combined buyer network spans 18 named purchasing companies, including CIPLA MAROC, CIPLA MAROC ANGLE RU, TORRENT PHARMA INC, TORRENT PHARMA INC IMPORTER EIN 36-4547412, HEUMANN PHARMA GMBH and 13 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MEDISPRAY LABORATORIES PRIVATE LIMITED
MEDISPRAY LABORATORIES PRIVATE LIMITED is the first-largest Citalopram exporter from India, with a market share of 30.4% and a total export value of $77.3M across 77 shipments. Their average shipment value of $1.0M is above the market average of $34.5K, suggesting premium or bulk contract pricing.
MEDISPRAY LABORATORIES PRIVATE LIMITED serves 3 named buyers in our database. CIPLA MAROC is the dominant customer, accounting for 99.5% of this supplier's tracked business. Top customers include:
• CIPLA MAROC — $77.0M across 77 shipments (99.5% of this supplier's total exports)
• CIPLA MAROC ANGLE RU — $214.9K across 0 shipments (0.3% of this supplier's total exports)
• CIPLA MAROC — $135.2K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: MEDISPRAY LABORATORIES PRIVATE LIMITED's per-shipment value of $1.0M is 2809% above the market average of $34.5K, consistent with large-order contracts or value-added formulations.
2TORRENT PHARMACEUTICALS LTD
TORRENT PHARMACEUTICALS LTD is the second-largest Citalopram exporter from India, with a market share of 5.6% and a total export value of $14.4M across 345 shipments. Their average shipment value of $41.6K is above the market average of $34.5K, suggesting premium or bulk contract pricing.
TORRENT PHARMACEUTICALS LTD serves 5 named buyers in our database. TORRENT PHARMA INC is the dominant customer, accounting for 77.5% of this supplier's tracked business. Top customers include:
• TORRENT PHARMA INC — $11.1M across 267 shipments (77.5% of this supplier's total exports)
• TORRENT PHARMA INC IMPORTER EIN 36-4547412 — $1.4M across 34 shipments (9.9% of this supplier's total exports)
• HEUMANN PHARMA GMBH — $806.5K across 19 shipments (5.6% of this supplier's total exports)
• DKSH MALAYSIA SDN BH — $526.1K across 13 shipments (3.7% of this supplier's total exports)
• TORRENT DO BRASIL LT — $471.4K across 11 shipments (3.3% of this supplier's total exports)
Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $41.6K is 21% above the market average of $34.5K, consistent with large-order contracts or value-added formulations.
3MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the third-largest Citalopram exporter from India, with a market share of 5.2% and a total export value of $13.3M across 202 shipments. Their average shipment value of $65.8K is above the market average of $34.5K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN PHARMACEUTICALS INC, is the dominant customer, accounting for 82.9% of this supplier's tracked business. Top customers include:
• MYLAN PHARMACEUTICALS INC, — $11.0M across 168 shipments (82.9% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC, — $1.5M across 23 shipments (11.2% of this supplier's total exports)
• MYLAN HUNGARY KFT, — $287.9K across 4 shipments (2.2% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC, — $276.0K across 4 shipments (2.1% of this supplier's total exports)
• MYLAN HUNGARY KFT, — $219.7K across 3 shipments (1.7% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $65.8K is 91% above the market average of $34.5K, consistent with large-order contracts or value-added formulations.
4SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Citalopram exporter from India, with a market share of 4.5% and a total export value of $11.5M across 463 shipments. Their average shipment value of $24.7K is below the market average of $34.5K, reflecting a high-volume, competitive pricing strategy.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 76.9% of this supplier's tracked business. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM — $8.8M across 356 shipments (76.9% of this supplier's total exports)
• RANBAXY (THAILAND) C — $855.6K across 35 shipments (7.5% of this supplier's total exports)
• M S SUN PHARMACEUTIC — $770.0K across 31 shipments (6.7% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $518.7K across 21 shipments (4.5% of this supplier's total exports)
• M/S. RANBAXY FARMACEUTICA LTDA : — $507.2K across 20 shipments (4.4% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (463 shipments) at a per-shipment value of $24.7K, indicating a broad distribution network with many smaller, regular orders.
5AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the fifth-largest Citalopram exporter from India, with a market share of 4.2% and a total export value of $10.6M across 1.0K shipments. Their average shipment value of $10.2K is below the market average of $34.5K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC AUROBINDO PHARM — $4.7M across 458 shipments (44.2% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $2.2M across 211 shipments (20.4% of this supplier's total exports)
• APL SWIFT SERVICES ( — $1.4M across 139 shipments (13.4% of this supplier's total exports)
• AUROLOGISTICS LLC — $1.2M across 121 shipments (11.7% of this supplier's total exports)
• AURO PHARMA INC — $1.1M across 106 shipments (10.3% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (1.0K shipments) at a per-shipment value of $10.2K, indicating a broad distribution network with many smaller, regular orders.
6AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED is the fifth-largest Citalopram exporter from India, with a market share of 3.1% and a total export value of $7.9M across 420 shipments. Their average shipment value of $18.9K is below the market average of $34.5K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC AUROBINDO PHARM — $3.9M across 204 shipments (48.6% of this supplier's total exports)
• AUROLOGISTICS LLC — $2.0M across 104 shipments (24.8% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $717.3K across 38 shipments (9.1% of this supplier's total exports)
• ORION CORPORATION — $703.7K across 37 shipments (8.9% of this supplier's total exports)
• AURO PHARMA INC — $683.5K across 36 shipments (8.6% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LIMITED operates with high shipment frequency (420 shipments) at a per-shipment value of $18.9K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Citalopram Flows
Once Citalopram leaves the manufacturing plants of companies like MEDISPRAY LABORATORIES PRIVATE LIMITED and TORRENT PHARMACEUTICALS LTD, it travels to 5 destination markets with a combined import value of $254.5M. Morocco absorbs the largest share at 31.6% ($80.4M), followed by United States (28.8%) and Belgium (4.7%).
In Morocco — the top destination — named importers include CIPLA MAROC. In United States, key buyers are TORRENT PHARMA INC, MYLAN PHARMACEUTICALS INC, AUROLOGISTICS LLC (AUROBINDO PHARMA.
This geographic spread reflects Citalopram's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Citalopram Go? Top Importing Countries & Their Buyers
Trade flow of Citalopram exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Morocco
Morocco ranks as the first-largest destination for Citalopram imports from India, with a total trade value of $80.4M across 71 shipments — representing a 31.6% share of all Citalopram exports. The average shipment value of $1.1M is above the global average of $34.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Citalopram importers in Morocco: CIPLA MAROC is the largest buyer, accounting for 96.0% ($77.2M) of this market's total imports.
• CIPLA MAROC — $77.2M (96.0% of Morocco's total)
Key Insight: Morocco's per-shipment average of $1.1M (3180% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Morocco is a key market for Citalopram imports from India.
2United States
United States ranks as the second-largest destination for Citalopram imports from India, with a total trade value of $73.4M across 758 shipments — representing a 28.8% share of all Citalopram exports. The average shipment value of $96.8K is above the global average of $34.5K, indicating high-value procurement contracts or branded formulations. This market is served by 11 tracked buyers.
Named Citalopram importers in United States: TORRENT PHARMA INC is the largest buyer, accounting for 20.7% ($15.2M) of this market's total imports.
• TORRENT PHARMA INC — $15.2M (20.7% of United States's total)
• MYLAN PHARMACEUTICALS INC — $11.9M (16.2% of United States's total)
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $5.4M (7.4% of United States's total)
Key Insight: United States's per-shipment average of $96.8K (180% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Citalopram imports from India.
3Belgium
Belgium ranks as the third-largest destination for Citalopram imports from India, with a total trade value of $12.0M across 179 shipments — representing a 4.7% share of all Citalopram exports. The average shipment value of $67.2K is above the global average of $34.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Citalopram importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 79.9% ($9.6M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $9.6M (79.9% of Belgium's total)
Key Insight: Belgium's per-shipment average of $67.2K (95% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Citalopram imports from India.
4Brazil
Brazil ranks as the fourth-largest destination for Citalopram imports from India, with a total trade value of $10.7M across 91 shipments — representing a 4.2% share of all Citalopram exports. The average shipment value of $117.7K is above the global average of $34.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Citalopram importers in Brazil: M/S. RANBAXY FARMACEUTICA LTDA : is the largest buyer, accounting for 41.6% ($4.5M) of this market's total imports.
• M/S. RANBAXY FARMACEUTICA LTDA : — $4.5M (41.6% of Brazil's total)
• SANDOZ DO BRASIL IND FARMACEUTICA — $1.8M (16.6% of Brazil's total)
Key Insight: Brazil's per-shipment average of $117.7K (241% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Citalopram imports from India.
5Canada
Canada ranks as the fifth-largest destination for Citalopram imports from India, with a total trade value of $10.1M across 0 shipments — representing a 4.0% share of all Citalopram exports. The average shipment value of $10.1M is above the global average of $34.5K, indicating high-value procurement contracts or branded formulations.
Key Insight: Canada's per-shipment average of $10.1M (29278% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Citalopram imports from India.
People Also Ask — Citalopram Supplier & Trade Network
Who are the top suppliers of Citalopram from India?+
Which companies buy Citalopram from Indian manufacturers?+
Where does Citalopram exported from India go?+
What is the market share of the top Citalopram supplier from India?+
What is the average shipment value for Citalopram exports from India?+
Is Citalopram manufactured in India and exported globally?+
Which country imports the most Citalopram from India?+
Who are the buyers of Citalopram in United States?+
How concentrated is the Citalopram supplier market in India?+
How do I find verified buyers for Citalopram in specific countries?+
Citalopram Trade Network — Key Takeaways
- 1MEDISPRAY LABORATORIES PRIVATE LIMITED is India's dominant Citalopram exporter with a 30.4% market share and $77.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 257 suppliers collectively account for 53.0% of all tracked Citalopram exports, with a combined trade value of $254.5M.
- 3Morocco is the largest destination market, absorbing 31.6% of India's Citalopram exports ($80.4M). United States (28.8%) and Belgium (4.7%) follow.
- 4With 7.4K total shipments averaging $34.5K each, the Citalopram export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include CIPLA MAROC, CIPLA MAROC ANGLE RU, TORRENT PHARMA INC, TORRENT PHARMA INC IMPORTER EIN 36-4547412 — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 3 customers
6 suppliers → 101 countries
Network value: $254.5M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Citalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Citalopram.
- 2.Flow Mapping: 257 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 7,372 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 101 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7,372 Verified Shipments
257 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists